Physician profile
Frederick Shuler
NPI 1215919220
$1,746.97
in general payments reported to CMS, 2019-2025
13 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $256 · 2021: $242 · 2022: $292 · 2023: $353 · 2024: $112 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $583.75 | 2021-2024 | Venclose Maven Catheter |
| Medtronic, INC. | $361.73 | 2021-2025 | Venaseal |
| Janssen Pharmaceuticals, INC | $299.48 | 2019-2023 | Xarelto |
| Venclose INC. | $165.93 | 2020 | |
| Medtronic Vascular, INC. | $123.43 | 2019-2020 | |
| Inari Medical, INC. | $53.37 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Organogenesis INC. | $53.27 | 2021-2025 | Apligraf |
| Philips North America LLC | $20.83 | 2019 | |
| Csl Behring | $19.40 | 2019 | |
| Smith+Nephew, INC. | $19.02 | 2024 | Collagenase Santyl |
| E.R. Squibb & Sons, L.L.C. | $18.97 | 2024 | Eliquis |
| Biocompatibles, INC. | $14.33 | 2019 | |
| Boston Scientific Corporation | $13.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Shuler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.